Automation

WHITE PAPERS AND CASE STUDIES

• A New Era Of ADC Development Demands A New Kind Of Partner

  Explore how to navigate the evolution of antibody-drug conjugates by mastering AI-driven selection, dose optimization, and new regulatory strategies for earlier-line clinical success.

• Operational Success By Strategic Investment

  Explore how infrastructure, equipment strategy, and advanced technologies shape a more reliable path for scaling sterile injectable programs.

• Cell Line Development For Bispecific Antibodies

  See how the recently described cell line development paradigm shift, enabled by the Leap-In transposon platform, can extend to the development of bispecific monoclonal antibody-producing cell substrates.

• Incorrect Clinical Trial Enrollment Is Preventable. A Tale Of Three Case Studies

  See how three clinical trials used centralized eligibility review to accelerate enrollment, eliminate enrollment-based protocol deviations, and keep studies on track, even at a global scale.

• Process Intensification And Other Ways To Adapt To Changing Needs

  As biologics manufacturing evolves, gain insight into why productivity depends on smarter investments, flexible production strategies, and supplier support that can address shifting modalities.

• Faster Starts, Stronger Finish: Operational Excellence In NSCLC

  In NSCLC trials, data‑driven site selection, streamlined protocols, efficient screening strategies, and proactive engagement can accelerate enrollment and improve trial efficiency across regions.

• Untapped Potential In Animal Health Innovation

  Animal health innovation is driving rapid market growth, fueled by rising demand and complexity, creating opportunities for advanced therapies, sustainability, and better disease management.

• Study Start-Up Challenges: Hard Realities, Effective Strategies

  Launching a study is complex, and the time between protocol approval and the first patient visit has increased dramatically. How can companies reverse this trend and accelerate study start-ups?

• Oligonucleotide Synthesis: Scale-Up Made Simple

  Scaling oligonucleotide synthesis isn't as straightforward as it seems. Explore key challenges, critical process parameters, and solutions for a smooth scale-up.

• Overcoming Analytical Bottlenecks In Oligonucleotide Drug Development With Automation

  Growing oligonucleotide complexity is straining traditional analytical workflows. See how automated LC‑UV‑MS processing offers a scalable way to boost throughput and reduce manual effort.

• Delivering Specialist Neurology Support

  Explore a strategic approach to a Parkinson’s disease trial that leveraged a global infrastructure and multilingual workforce to provide seamless operational and clinical support.

• Advanced Leak Detection Safeguards Water In Utqiaġvik, Alaska

  In the remote Arctic village of Utqiaġvik, Alaska — where extreme winters and frozen terrain make traditional water system maintenance nearly impossible — the Ukpeaġvik Iñupiat Corporation (UIC) faced a critical threat: a persistent underground leak draining over 10,000 gallons of water per day.